Open Actively Recruiting

Measuring Patient-Reported Outcomes (symptoms and quality of life) Related to Radiopharmaceuticals for Prostate Cancer: a post-hoc Retrospective study of the RESIST-PC Trial (NCT03042312, IRB#17-000330).

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
20-001101
Category
Prostate Cancer